Who is saying what about Inflammatory Bowel Disease on Twitter?
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Background

• With about 330 million active users and its growing media attention
globally, Twitter is a powerful tool for conveying information to the general
population.
• There is limited data on the utilization of Twitter for disseminating medical
information.
• This study evaluated messages on Twitter regarding IBD.

Figure 1. Twitter Users Discussing IBD

Methods

• Social Feed Manager (SFM; version 1.10.0; GW University, 2017), a software
that mines social media platforms, was used to extract information
regarding IBD-related tweets and their accounts over a 10-day period.
• We queried Twitter for terms related to IBD and categorized messages by
geographic origin, type of user, and message content.
• Statistical analysis was conducted using a two-tailed Fisher’s Exact Test with
a significance set at p< 0.05.

Results

• Our study analyzed 629 consecutive IBD-related messages worldwide.
• The vast majority of tweets came from the USA (41.7%) and UK (35.7%), with
fewer from Canada (9.9%), South America (8.5%), Asia (3.2%), and Australia
(0.9%).
• These messages were posted by 578 distinct users (Figure 1), with patients
(20.9%) and clinicians (21.1%) being the most common.
• General disease information was discussed by patients and support groups
more than by clinicians, industry, foundations, and advocates (39.2% vs. 23.6%;
p=0.0002), with symptoms being discussed by patients more than all other
groups (23.1% vs. 8.0%; p=0.0001).
• Disease management was discussed by clinicians, industry, and foundations
more than by patients, advocates and support groups (52.9% vs. 28.5%;
p=0.0001).
• Direct recommendations were made more by clinicians and industry than other
groups (5.6% vs. 0.8%; p=0.0018), with industry making more
recommendations than clinicians (13.2% vs. 3.3%; p=0.0353).

Discussion
• This study reveals that Twitter is utilized by a variety of people and provides
diverse messaging about IBD.
• Patients and support groups tweeted more about general disease
information, while clinicians, industry, and foundations tweeted more about
disease management.
• Patients alone discussed symptoms in their messages.
• Clinicians and industry made more management recommendations than any
other group, while industry made more direct recommendations than
clinicians.
• It is critical that users are aware that Twitter messaging provides unfiltered
medical information and that the validity of message content always should
be considered.

